|
AP3M1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.83079999996438E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98709999998936E-06 |
| Normal-vs-Stage2 |
5.184300E-02 |
| Normal-vs-Stage3 |
1.478190E-02 |
| Normal-vs-Stage4 |
2.047800E-01 |
| Stage1-vs-Stage2 |
4.816600E-01 |
| Stage1-vs-Stage3 |
5.325000E-01 |
| Stage1-vs-Stage4 |
6.724600E-01 |
| Stage2-vs-Stage3 |
8.688600E-01 |
| Stage2-vs-Stage4 |
9.288600E-01 |
| Stage3-vs-Stage4 |
9.763800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.65929999998527E-06 |
| Normal-vs-AfricanAmerican |
3.545000E-03 |
| Normal-vs-Asian |
3.698000E-01 |
| Caucasian-vs-AfricanAmerican |
5.994000E-01 |
| Caucasian-vs-Asian |
6.686000E-01 |
| AfricanAmerican-vs-Asian |
7.913000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0151000302302E-09 |
| Normal-vs-Female |
8.168000E-01 |
| Male-vs-Female |
2.979100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.987470E-04 |
| Normal-vs-Extreme_Weight |
3.45649999733411E-08 |
| Normal-vs-Obese |
4.199300E-03 |
| Normal-vs-Extreme_Obese |
1.355960E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.871200E-01 |
| Normal_Weight-vs-Obese |
2.322200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.125600E-01 |
| Extreme_Weight-vs-Obese |
2.211900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.990200E-01 |
| Obese-vs-Extreme_Obese |
2.168000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.555600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.980900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.99820000049245E-07 |
| Normal-vs-Age(81-100Yrs) |
2.767700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.820600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.144200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.001100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.914000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.914200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.502600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.39650000031378E-08 |
| Normal-VS-Type2 PRCC |
3.63930000000234E-05 |
| Normal-VS-KIRP CIMP |
8.498800E-01 |
| Normal-VS-Unclassified PRCC |
5.251400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.856200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.565900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.561600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.141600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.044300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.342800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76282999999611E-05 |
| Normal-vs-N1 |
2.903800E-01 |
| Normal-vs-N2 |
6.763200E-01 |
| N0-vs-N1 |
4.829700E-02 |
| N0-vs-N2 |
5.215800E-01 |
| N1-vs-N2 |
8.084000E-01 |
|
|
